Hubei Jumpcan Pharmaceutical Co., Ltd. (SHA:600566)

SHA:600566 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6,669	7,738	4,819	3,819	2,959
Trading Asset Securities	5,161	3,178	3,045	1,675	1,258
Cash & Short-Term Investments	11,830	10,916	7,863	5,494	4,217
Cash Growth	8.37%	38.82%	43.13%	30.28%	70.40%
Accounts Receivable	2,257	2,782	2,850	2,183	2,032
Other Receivables	12.5	14.99	17.2	11.98	10.33
Receivables	2,270	2,797	2,867	2,195	2,042
Inventory	569.09	490.08	391.48	375.59	278.42
Other Current Assets	32.6	32.5	54.23	58.34	38.13
Total Current Assets	14,702	14,235	11,177	8,123	6,576
Property, Plant & Equipment	2,706	2,922	2,856	3,034	3,141
Long-Term Investments	464.71	393.97	332.34	328.44	155.33
Goodwill	167.3	167.3	167.3	167.3	167.3
Other Intangible Assets	308.56	305.01	320.62	280.04	283.84
Long-Term Deferred Tax Assets	41.83	45.45	62.16	57.32	42.62
Long-Term Deferred Charges	2.38	11.91	3.87	13.19	23.67
Other Long-Term Assets	66.44	62.16	62.14	127.96	126.51
Total Assets	18,459	18,144	14,981	12,131	10,516
Accounts Payable	1,730	2,141	1,505	945.77	452.52
Accrued Expenses	153.89	246.62	350.39	242.7	207.74
Short-Term Debt	787.15	1,088	400	-	-
Current Portion of Long-Term Debt	1.07	-	-	627.55	-
Current Portion of Leases	-	1.06	0.44	1.55	-
Current Income Taxes Payable	204.41	182.62	106.09	43.71	69.64
Current Unearned Revenue	17.92	17.25	49.14	19.34	8.03
Other Current Liabilities	643.58	915.86	1,016	919.98	1,229
Total Current Liabilities	3,538	4,592	3,427	2,801	1,967
Long-Term Debt	-	-	-	-	602.58
Long-Term Leases	1.04	1.43	0.2	1.02	-
Long-Term Unearned Revenue	65.45	71.43	78.19	84.63	90.67
Long-Term Deferred Tax Liabilities	127.84	109.28	122.05	112.38	90.72
Other Long-Term Liabilities	0.53	0.82	1.06	1.35	1.67
Total Liabilities	3,733	4,775	3,629	3,000	2,753
Common Stock	452.69	452.74	452.74	436.27	436.26
Additional Paid-In Capital	4,012	3,999	3,984	3,148	3,114
Retained Earnings	10,345	9,010	6,998	5,431	4,112
Treasury Stock	-108.57	-111.97	-97.18	-	-
Comprehensive Income & Other	-	-	-	100.81	100.87
Total Common Equity	14,702	13,349	11,337	9,117	7,763
Minority Interest	24.57	19.42	15.14	14.17	-
Shareholders' Equity	14,726	13,369	11,352	9,131	7,763
Total Liabilities & Equity	18,459	18,144	14,981	12,131	10,516
Total Debt	789.26	1,090	400.65	630.12	602.58
Net Cash (Debt)	11,041	9,826	7,463	4,864	3,615
Net Cash Growth	12.37%	31.67%	53.43%	34.56%	90.37%
Net Cash Per Share	12.04	10.72	8.22	5.40	4.33
Filing Date Shares Outstanding	912.53	921.81	921.82	888.27	888.26
Total Common Shares Outstanding	912.53	921.81	921.82	888.27	888.26
Working Capital	11,164	9,644	7,749	5,322	4,609
Book Value Per Share	16.11	14.48	12.30	10.26	8.74
Tangible Book Value	14,226	12,877	10,849	8,670	7,312
Tangible Book Value Per Share	15.59	13.97	11.77	9.76	8.23
Buildings	-	2,911	2,455	2,473	2,362
Machinery	-	1,685	1,644	1,566	1,488
Construction In Progress	-	186.98	352.15	322.17	364.89

Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.